Evaluation of European severe acute respiratory infection (SARI) surveillance, 27 European countries, 2022/23
BackgroundBetween 2020 and 2023, ECDC has supported 21 of 30 EU/EEA and six Western Balkan countries by enhancing severe acute respiratory infection (SARI) surveillance to monitor trends, detect unexpected events, evaluate public health interventions, identify risk factors and support vaccine effectiveness studies. Using diverse strategies, countries have implemented SARI surveillance and reported data at national/European levels.AimWe evaluated European-level SARI surveillance and provided recommendations to achieve objectives and improve key attribute performance.MethodsWe analysed 2022/23 surveillance data for completeness. We administered a questionnaire, targeting country-level representatives, to evaluate surveillance attributes (meeting objectives, usefulness, acceptability, timeliness, representativeness) and identify strengths, weaknesses, opportunities and threats.ResultsThirteen countries (13/27) reported data at European level. Data showed good overall completeness but varied across countries and some variables need improvement (vaccination, sequencing). The questionnaire was completed by all 27 countries. Most countries (23/27) reported that the system effectively monitored trends and considered it useful and acceptable (25/27), but only 16 found it timely and 14 representative. Challenges included insufficient case-based data, data linkage issues and insufficient data completeness. Slow/inefficient manual data extraction affected timeliness, while insufficient geographical coverage affected representativeness. Multi-pathogen surveillance was identified as the main strength, heterogeneity of systems the main weakness, improvements of hospital information systems the main opportunity, and lack of sustainable funding the main threat.ConclusionsSARI surveillance was perceived as effective in monitoring trends, useful and acceptable. To achieve additional objectives and enhance timeliness and representativeness, we recommend improving data completeness, digitalisation/automation and geographical coverage.
Authors
- Hanne‐Dorthe Emborg (ORCID: https://orcid.org/0000-0001-8062-0864)
- Mariëtte Hooiveld (ORCID: https://orcid.org/0000-0002-5513-1740)
- Lisa Domegan (ORCID: https://orcid.org/0000-0002-7483-6703)
- Diogo FP Marques (ORCID: https://orcid.org/0000-0002-2556-0923)
- Dory Kovacs
- Susana Monge (ORCID: https://orcid.org/0000-0003-1412-3012)
- Ana Paula Rodrigues (ORCID: https://orcid.org/0000-0003-2264-4723)
- Ausenda Machado (ORCID: https://orcid.org/0000-0002-1849-1499)
- Carlos Carvalho (ORCID: https://orcid.org/0000-0001-7979-7283)
- Angela MC Rose (ORCID: https://orcid.org/0000-0002-2493-8082)
- Clara Mazagatos (ORCID: https://orcid.org/0000-0002-6909-6923)
- Joan O’Donnell (ORCID: https://orcid.org/0000-0002-2662-6306)
- Baltazar Nunes (ORCID: https://orcid.org/0000-0001-6230-7209)
- Marco Ruiz (ORCID: https://orcid.org/0000-0001-7807-1552)
Institutions
- Statens Serum Institut (DK)
- Instituto de Salud Carlos III (ES)
- Netherlands Institute for Health Services Research (NL)
- Centro de Investigación Biomédica en Red (ES)
- Health Protection Surveillance Centre (IE)
- National Institute of Health Dr. Ricardo Jorge (PT)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
- European Centre for Disease Prevention and Control (SE)
- Universidade Nova de Lisboa (PT)
Publication Details
- Journal
- Eurosurveillance
- Published
- 2025-05-22
- DOI
- https://doi.org/10.2807/1560-7917.es.2025.30.20.2400655
- Citations
- 1
- Primary Topic
- Data-Driven Disease Surveillance
- Type
- article
- Field-Weighted Citation Impact
- 1.35